U.S. Approves First Self-Administered Nasal Flu Vaccine
The U.S. FDA has approved AstraZeneca’s FluMist nasal spray as the first self-administered flu vaccine, offering a needle-free option to boost vaccination rates and improve accessibility.
AstraZeneca FluMist
Read More